Detection of severe fever with thrombocytopenia syndrome virus by reverse transcription-cross-priming amplification coupled with vertical flow visualization

Lunbiao Cui, Yiyue Ge, Xian Qi, Gaolian Xu, Haijing Li, Kangchen Zhao, Bin Wu, Zhiyang Shi, Xiling Guo, Lin Hu, Qimin You, Li Hong Zhang, Alexander Freiberg, Xuejie Yu, Hua Wang, Minghao Zhou, Yi Wei Tang

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

A virus known as severe fever with thrombocytopenia syndrome virus (SFTSV) was recently identified as the etiological agent of severe fever with thrombocytopenia syndrome (SFTS) in China. Reliable laboratory detection and identification of this virus are likely to become clinically and epidemiologically desirable. We developed a nearly instrument-free, simple molecular method which incorporates reverse transcription-cross-priming amplification (RT-CPA) coupled with a vertical flow (VF) visualization strip for rapid detection of SFTSV. The RT-CPA-VF assay targets a conserved region of theMsegment of the SFTSV genome and has a limit of detection of 100 copies per reaction, with no cross-reaction with other vector-borne bunyaviruses and bacterial pathogens. The performance of the RT-CPA-VF assay was determined with 175 human plasma specimens collected from 89 clinically suspected SFTS patients and 86 healthy donors. The sensitivity and specificity of the assay were 94.1% and 100.0%, respectively, compared with a combination of virus culture and real-time RT-PCR. The entire procedure, from specimen processing to result reporting, can be completed within 2 h. The simplicity and nearly instrument-free platform of the RT-CPA-VF assay make it practical for point-of-care testing.

Original languageEnglish (US)
Pages (from-to)3881-3885
Number of pages5
JournalJournal of Clinical Microbiology
Volume50
Issue number12
DOIs
StatePublished - Dec 2012

Fingerprint

Cross-Priming
Thrombocytopenia
Reverse Transcription
Fever
Viruses
Orthobunyavirus
Cross Reactions
Limit of Detection
Real-Time Polymerase Chain Reaction
China
Tissue Donors
Genome
Sensitivity and Specificity

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Detection of severe fever with thrombocytopenia syndrome virus by reverse transcription-cross-priming amplification coupled with vertical flow visualization. / Cui, Lunbiao; Ge, Yiyue; Qi, Xian; Xu, Gaolian; Li, Haijing; Zhao, Kangchen; Wu, Bin; Shi, Zhiyang; Guo, Xiling; Hu, Lin; You, Qimin; Zhang, Li Hong; Freiberg, Alexander; Yu, Xuejie; Wang, Hua; Zhou, Minghao; Tang, Yi Wei.

In: Journal of Clinical Microbiology, Vol. 50, No. 12, 12.2012, p. 3881-3885.

Research output: Contribution to journalArticle

Cui, L, Ge, Y, Qi, X, Xu, G, Li, H, Zhao, K, Wu, B, Shi, Z, Guo, X, Hu, L, You, Q, Zhang, LH, Freiberg, A, Yu, X, Wang, H, Zhou, M & Tang, YW 2012, 'Detection of severe fever with thrombocytopenia syndrome virus by reverse transcription-cross-priming amplification coupled with vertical flow visualization', Journal of Clinical Microbiology, vol. 50, no. 12, pp. 3881-3885. https://doi.org/10.1128/JCM.01931-12
Cui, Lunbiao ; Ge, Yiyue ; Qi, Xian ; Xu, Gaolian ; Li, Haijing ; Zhao, Kangchen ; Wu, Bin ; Shi, Zhiyang ; Guo, Xiling ; Hu, Lin ; You, Qimin ; Zhang, Li Hong ; Freiberg, Alexander ; Yu, Xuejie ; Wang, Hua ; Zhou, Minghao ; Tang, Yi Wei. / Detection of severe fever with thrombocytopenia syndrome virus by reverse transcription-cross-priming amplification coupled with vertical flow visualization. In: Journal of Clinical Microbiology. 2012 ; Vol. 50, No. 12. pp. 3881-3885.
@article{59d1258135c14feea53542263773c409,
title = "Detection of severe fever with thrombocytopenia syndrome virus by reverse transcription-cross-priming amplification coupled with vertical flow visualization",
abstract = "A virus known as severe fever with thrombocytopenia syndrome virus (SFTSV) was recently identified as the etiological agent of severe fever with thrombocytopenia syndrome (SFTS) in China. Reliable laboratory detection and identification of this virus are likely to become clinically and epidemiologically desirable. We developed a nearly instrument-free, simple molecular method which incorporates reverse transcription-cross-priming amplification (RT-CPA) coupled with a vertical flow (VF) visualization strip for rapid detection of SFTSV. The RT-CPA-VF assay targets a conserved region of theMsegment of the SFTSV genome and has a limit of detection of 100 copies per reaction, with no cross-reaction with other vector-borne bunyaviruses and bacterial pathogens. The performance of the RT-CPA-VF assay was determined with 175 human plasma specimens collected from 89 clinically suspected SFTS patients and 86 healthy donors. The sensitivity and specificity of the assay were 94.1{\%} and 100.0{\%}, respectively, compared with a combination of virus culture and real-time RT-PCR. The entire procedure, from specimen processing to result reporting, can be completed within 2 h. The simplicity and nearly instrument-free platform of the RT-CPA-VF assay make it practical for point-of-care testing.",
author = "Lunbiao Cui and Yiyue Ge and Xian Qi and Gaolian Xu and Haijing Li and Kangchen Zhao and Bin Wu and Zhiyang Shi and Xiling Guo and Lin Hu and Qimin You and Zhang, {Li Hong} and Alexander Freiberg and Xuejie Yu and Hua Wang and Minghao Zhou and Tang, {Yi Wei}",
year = "2012",
month = "12",
doi = "10.1128/JCM.01931-12",
language = "English (US)",
volume = "50",
pages = "3881--3885",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "12",

}

TY - JOUR

T1 - Detection of severe fever with thrombocytopenia syndrome virus by reverse transcription-cross-priming amplification coupled with vertical flow visualization

AU - Cui, Lunbiao

AU - Ge, Yiyue

AU - Qi, Xian

AU - Xu, Gaolian

AU - Li, Haijing

AU - Zhao, Kangchen

AU - Wu, Bin

AU - Shi, Zhiyang

AU - Guo, Xiling

AU - Hu, Lin

AU - You, Qimin

AU - Zhang, Li Hong

AU - Freiberg, Alexander

AU - Yu, Xuejie

AU - Wang, Hua

AU - Zhou, Minghao

AU - Tang, Yi Wei

PY - 2012/12

Y1 - 2012/12

N2 - A virus known as severe fever with thrombocytopenia syndrome virus (SFTSV) was recently identified as the etiological agent of severe fever with thrombocytopenia syndrome (SFTS) in China. Reliable laboratory detection and identification of this virus are likely to become clinically and epidemiologically desirable. We developed a nearly instrument-free, simple molecular method which incorporates reverse transcription-cross-priming amplification (RT-CPA) coupled with a vertical flow (VF) visualization strip for rapid detection of SFTSV. The RT-CPA-VF assay targets a conserved region of theMsegment of the SFTSV genome and has a limit of detection of 100 copies per reaction, with no cross-reaction with other vector-borne bunyaviruses and bacterial pathogens. The performance of the RT-CPA-VF assay was determined with 175 human plasma specimens collected from 89 clinically suspected SFTS patients and 86 healthy donors. The sensitivity and specificity of the assay were 94.1% and 100.0%, respectively, compared with a combination of virus culture and real-time RT-PCR. The entire procedure, from specimen processing to result reporting, can be completed within 2 h. The simplicity and nearly instrument-free platform of the RT-CPA-VF assay make it practical for point-of-care testing.

AB - A virus known as severe fever with thrombocytopenia syndrome virus (SFTSV) was recently identified as the etiological agent of severe fever with thrombocytopenia syndrome (SFTS) in China. Reliable laboratory detection and identification of this virus are likely to become clinically and epidemiologically desirable. We developed a nearly instrument-free, simple molecular method which incorporates reverse transcription-cross-priming amplification (RT-CPA) coupled with a vertical flow (VF) visualization strip for rapid detection of SFTSV. The RT-CPA-VF assay targets a conserved region of theMsegment of the SFTSV genome and has a limit of detection of 100 copies per reaction, with no cross-reaction with other vector-borne bunyaviruses and bacterial pathogens. The performance of the RT-CPA-VF assay was determined with 175 human plasma specimens collected from 89 clinically suspected SFTS patients and 86 healthy donors. The sensitivity and specificity of the assay were 94.1% and 100.0%, respectively, compared with a combination of virus culture and real-time RT-PCR. The entire procedure, from specimen processing to result reporting, can be completed within 2 h. The simplicity and nearly instrument-free platform of the RT-CPA-VF assay make it practical for point-of-care testing.

UR - http://www.scopus.com/inward/record.url?scp=84869228754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869228754&partnerID=8YFLogxK

U2 - 10.1128/JCM.01931-12

DO - 10.1128/JCM.01931-12

M3 - Article

VL - 50

SP - 3881

EP - 3885

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 12

ER -